Larry Ellison bankrolling £118M vaccine research at Oxford
4 Articles
4 Articles
Oxford secures £118m for AI-driven vaccine research with Ellison Institute
The University of Oxford has launched a £118m AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials A new initiative, led by Oxford Vaccine Group, named CoI-AI (Correlates of Immunity-Artificial Intelligence), will combine Oxford’s expertise in human challenge studies, immune science, and vaccine development with the Ellison Institute of Technology (EIT)’s Artific…
Oracle’s billionaire president’s technology institute, Larry Ellison, will fund a pioneering project that uses artificial intelligence for the research of...
Larry Ellison bankrolling £118M AI vaccine research at Oxford University
Oracle billionaire funds project to predict immunity and develop treatments for hard-to-prevent diseases A research group funded by tech billionaire Larry Ellison is set to invest £118 million ($169.6 million) in applying AI to vaccine research with the UK's Oxford University. . . .
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

